Page 5 - 2019_11 Resto del Mondo-web

Table of Contents
Volume 104, Issue 11: November 2019
Cover Figure
haematologica Journal of the Ferrata Storti Foundation
Bone marrow smear from a patient with pure red cell aplasia showing marked erythroid hypoplasia with almost exclusive presence of early erythroid precursors. Courtesy of Prof. Rosangela Invernizzi.
Editorials
2117 Notch in the niche: new insights into the role of Notch signaling in the bone marrow Ashley N. Vanderbeck and Ivan Maillard
2119 Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?
Hans Carl Hasselbalch
2125 Standing at odds: mutated RAS and hematopoietic stem cells Monica Nafria and Constanze Bonifer
2128 Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update? Monika Engelhardt et al.
2132 The child with immune thrombocytopenia: to treat or not to treat, is that still the question? Nichola Cooper and Douglas B. Cines
Review Articles
2135 How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia Avraham Frisch and Yishai Ofran
2144 Sequential and combination treatments with novel agents in chronic lymphocytic leukemia Moritz Fürstenau et al.
Guideline Article
2155 Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation
Katherine N Ward et al.
Articles
Hematopoiesis
2164 A Tie2-Notch1 signaling axis regulates regeneration of the endothelial bone marrow niche Lijian Shao et al.
Red Cell Biology & its Disorders
2178 Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1 Long Liang et al.
2189 Altered parasite life-cycle processes characterize Babesia divergens infection in human sickle cell anemia Jeny R. Cursino-Santos et al.
Myeloproliferative Neoplasms
2200 Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values Richard T. Silver and Spencer Krichevsky
Chronic Myeloid Leukemia
2206 MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia Simone Claudiani et al.
Haematologica 2019; vol. 104 no. 11 - November 2019 http://www.haematologica.org/